[单核阳性活检前列腺癌患者术后病理升级的风险因素分析和提名图模型构建]。

Q3 Medicine
北京大学学报(医学版) Pub Date : 2024-10-18
Zhicun Li, Tianyu Wu, Lei Liang, Yu Fan, Yisen Meng, Qian Zhang
{"title":"[单核阳性活检前列腺癌患者术后病理升级的风险因素分析和提名图模型构建]。","authors":"Zhicun Li, Tianyu Wu, Lei Liang, Yu Fan, Yisen Meng, Qian Zhang","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To analyze the risk factors for postoperative pathological upgrade of prostate cancer patients with single core positive biopsy, and to attempt to build a mathematical model for predicting postoperative pathological upgrade in these cancer patients with single core positive biopsy.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 1 349 patients diagnosed with prostate cancer and undergoing radical prostatectomy at Peking University First Hospital from January 2015 to August 2020. The patients' age, body mass index, clinical stage, prostate imaging reporting and data system (PI-RADS) scores, prostate volume in magnetic resonance imaging (MRI), Gleason score of biopsy, serum prostate specific antigen (PSA) before biopsy and operation, surgical method and pathological stage were inclu-ded in the analysis. The variables with <i>P</i> < 0.1 in univariate analysis were included to construct multi-variate Logistic regression and the nomogram was drawn. The model was evaluated using the receiver operating curve.</p><p><strong>Results: </strong>A total of 71 patients were included in this research, with 34 patients in the upgraded group and 37 patients in the non-upgraded group. There were no significant differences in the patients' age (<i>P</i>=0.585), body mass index (<i>P</i>=0.165), operation method (<i>P</i>=0.08), prostate volume in MRI (<i>P</i>=0.067), clinical stage (<i>P</i>=0.678), PI-RADS score (<i>P</i>=0.203), difference of PSA density (<i>P</i>=0.063), Gleason score in biopsy (<i>P</i>=0.068), PSA before puncture (<i>P</i>=0.359) and operation (<i>P</i>= 0.739) between the two groups. However, there were significant differences in the proportion of tumor tissue (<i>P</i>=0.007), postoperative pathological stage (<i>P</i> < 0.001) and postoperative Gleason score (<i>P</i> < 0.001) between the two groups. The preoperative variables with a <i>P</i> value of less than 0.1 (prostate volume in MRI, difference of PSA density, proportion of tumor tissue and Gleason score in biopsy) in univariate analysis were included in the Logistic regression, and the nomogram was drawn. Only the prostate volume in MRI had a <i>P</i> value of less than 0.05. The area under the curve of the model was 0.773.</p><p><strong>Conclusion: </strong>In patients with single core positive biopsy, if the prostate volume is small or the proportion of tumor in positive core is small, clinicians should be alert to the possibility of postoperative pathology upgrading, preoperative risk stratification should be carefully considered for patients with possible pathological upgrading. This model can be used to predict the pathological upgrade of patients with single core positive biopsy.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"56 5","pages":"896-901"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480540/pdf/","citationCount":"0","resultStr":"{\"title\":\"[Risk factors analysis and nomogram model construction of postoperative pathological upgrade of prostate cancer patients with single core positive biopsy].\",\"authors\":\"Zhicun Li, Tianyu Wu, Lei Liang, Yu Fan, Yisen Meng, Qian Zhang\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To analyze the risk factors for postoperative pathological upgrade of prostate cancer patients with single core positive biopsy, and to attempt to build a mathematical model for predicting postoperative pathological upgrade in these cancer patients with single core positive biopsy.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 1 349 patients diagnosed with prostate cancer and undergoing radical prostatectomy at Peking University First Hospital from January 2015 to August 2020. The patients' age, body mass index, clinical stage, prostate imaging reporting and data system (PI-RADS) scores, prostate volume in magnetic resonance imaging (MRI), Gleason score of biopsy, serum prostate specific antigen (PSA) before biopsy and operation, surgical method and pathological stage were inclu-ded in the analysis. The variables with <i>P</i> < 0.1 in univariate analysis were included to construct multi-variate Logistic regression and the nomogram was drawn. The model was evaluated using the receiver operating curve.</p><p><strong>Results: </strong>A total of 71 patients were included in this research, with 34 patients in the upgraded group and 37 patients in the non-upgraded group. There were no significant differences in the patients' age (<i>P</i>=0.585), body mass index (<i>P</i>=0.165), operation method (<i>P</i>=0.08), prostate volume in MRI (<i>P</i>=0.067), clinical stage (<i>P</i>=0.678), PI-RADS score (<i>P</i>=0.203), difference of PSA density (<i>P</i>=0.063), Gleason score in biopsy (<i>P</i>=0.068), PSA before puncture (<i>P</i>=0.359) and operation (<i>P</i>= 0.739) between the two groups. However, there were significant differences in the proportion of tumor tissue (<i>P</i>=0.007), postoperative pathological stage (<i>P</i> < 0.001) and postoperative Gleason score (<i>P</i> < 0.001) between the two groups. The preoperative variables with a <i>P</i> value of less than 0.1 (prostate volume in MRI, difference of PSA density, proportion of tumor tissue and Gleason score in biopsy) in univariate analysis were included in the Logistic regression, and the nomogram was drawn. Only the prostate volume in MRI had a <i>P</i> value of less than 0.05. The area under the curve of the model was 0.773.</p><p><strong>Conclusion: </strong>In patients with single core positive biopsy, if the prostate volume is small or the proportion of tumor in positive core is small, clinicians should be alert to the possibility of postoperative pathology upgrading, preoperative risk stratification should be carefully considered for patients with possible pathological upgrading. This model can be used to predict the pathological upgrade of patients with single core positive biopsy.</p>\",\"PeriodicalId\":8790,\"journal\":{\"name\":\"北京大学学报(医学版)\",\"volume\":\"56 5\",\"pages\":\"896-901\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480540/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"北京大学学报(医学版)\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"北京大学学报(医学版)","FirstCategoryId":"3","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目的分析单核活检阳性前列腺癌患者术后病理升级的风险因素,并尝试建立预测单核活检阳性前列腺癌患者术后病理升级的数学模型:方法:对2015年1月至2020年8月在北京大学第一医院确诊并接受前列腺癌根治术的1 349例患者进行回顾性分析。分析包括患者的年龄、体重指数、临床分期、前列腺影像报告和数据系统(PI-RADS)评分、磁共振成像(MRI)显示的前列腺体积、活检的格里森评分、活检和手术前的血清前列腺特异性抗原(PSA)、手术方法和病理分期。将单变量分析中P<0.1的变量纳入多变量Logistic回归,并绘制提名图。结果:本研究共纳入 71 例患者,其中升级组 34 例,非升级组 37 例。两组患者在年龄(P=0.585)、体重指数(P=0.165)、手术方式(P=0.08)、MRI检查前列腺体积(P=0.067)、临床分期(P=0.678)、PI-RADS评分(P=0.203)、PSA密度差异(P=0.063)、活检Gleason评分(P=0.068)、穿刺前PSA(P=0.359)、手术前PSA(P=0.739)等方面无明显差异。然而,两组患者的肿瘤组织比例(P=0.007)、术后病理分期(P<0.001)和术后 Gleason 评分(P<0.001)均有明显差异。单变量分析中 P 值小于 0.1 的术前变量(MRI 中的前列腺体积、PSA 密度差异、肿瘤组织比例和活检中的 Gleason 评分)被纳入 Logistic 回归,并绘制了提名图。只有 MRI 中的前列腺体积的 P 值小于 0.05。模型的曲线下面积为 0.773:对于单核阳性活检患者,如果前列腺体积较小或阳性核内肿瘤比例较小,临床医生应警惕术后病理升级的可能性,对于可能出现病理升级的患者,应慎重考虑术前风险分层。该模型可用于预测单核阳性活检患者的病理升级。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Risk factors analysis and nomogram model construction of postoperative pathological upgrade of prostate cancer patients with single core positive biopsy].

Objective: To analyze the risk factors for postoperative pathological upgrade of prostate cancer patients with single core positive biopsy, and to attempt to build a mathematical model for predicting postoperative pathological upgrade in these cancer patients with single core positive biopsy.

Methods: A retrospective analysis was conducted on 1 349 patients diagnosed with prostate cancer and undergoing radical prostatectomy at Peking University First Hospital from January 2015 to August 2020. The patients' age, body mass index, clinical stage, prostate imaging reporting and data system (PI-RADS) scores, prostate volume in magnetic resonance imaging (MRI), Gleason score of biopsy, serum prostate specific antigen (PSA) before biopsy and operation, surgical method and pathological stage were inclu-ded in the analysis. The variables with P < 0.1 in univariate analysis were included to construct multi-variate Logistic regression and the nomogram was drawn. The model was evaluated using the receiver operating curve.

Results: A total of 71 patients were included in this research, with 34 patients in the upgraded group and 37 patients in the non-upgraded group. There were no significant differences in the patients' age (P=0.585), body mass index (P=0.165), operation method (P=0.08), prostate volume in MRI (P=0.067), clinical stage (P=0.678), PI-RADS score (P=0.203), difference of PSA density (P=0.063), Gleason score in biopsy (P=0.068), PSA before puncture (P=0.359) and operation (P= 0.739) between the two groups. However, there were significant differences in the proportion of tumor tissue (P=0.007), postoperative pathological stage (P < 0.001) and postoperative Gleason score (P < 0.001) between the two groups. The preoperative variables with a P value of less than 0.1 (prostate volume in MRI, difference of PSA density, proportion of tumor tissue and Gleason score in biopsy) in univariate analysis were included in the Logistic regression, and the nomogram was drawn. Only the prostate volume in MRI had a P value of less than 0.05. The area under the curve of the model was 0.773.

Conclusion: In patients with single core positive biopsy, if the prostate volume is small or the proportion of tumor in positive core is small, clinicians should be alert to the possibility of postoperative pathology upgrading, preoperative risk stratification should be carefully considered for patients with possible pathological upgrading. This model can be used to predict the pathological upgrade of patients with single core positive biopsy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
北京大学学报(医学版)
北京大学学报(医学版) Medicine-Medicine (all)
CiteScore
0.80
自引率
0.00%
发文量
9815
期刊介绍: Beijing Da Xue Xue Bao Yi Xue Ban / Journal of Peking University (Health Sciences), established in 1959, is a national academic journal sponsored by Peking University, and its former name is Journal of Beijing Medical University. The coverage of the Journal includes basic medical sciences, clinical medicine, oral medicine, surgery, public health and epidemiology, pharmacology and pharmacy. Over the last few years, the Journal has published articles and reports covering major topics in the different special issues (e.g. research on disease genome, theory of drug withdrawal, mechanism and prevention of cardiovascular and cerebrovascular diseases, stomatology, orthopaedic, public health, urology and reproductive medicine). All the topics involve latest advances in medical sciences, hot topics in specific specialties, and prevention and treatment of major diseases. The Journal has been indexed and abstracted by PubMed Central (PMC), MEDLINE/PubMed, EBSCO, Embase, Scopus, Chemical Abstracts (CA), Western Pacific Region Index Medicus (WPR), JSTChina, and almost all the Chinese sciences and technical index systems, including Chinese Science and Technology Paper Citation Database (CSTPCD), Chinese Science Citation Database (CSCD), China BioMedical Bibliographic Database (CBM), CMCI, Chinese Biological Abstracts, China National Academic Magazine Data-Base (CNKI), Wanfang Data (ChinaInfo), etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信